Published in:
Open Access
01-12-2014 | Case report
De novo deletion of chromosome 11q12.3 in monozygotic twins affected by Poland Syndrome
Authors:
Carlotta Maria Vaccari, Maria Victoria Romanini, Ilaria Musante, Elisa Tassano, Stefania Gimelli, Maria Teresa Divizia, Michele Torre, Carmen Gloria Morovic, Margherita Lerone, Roberto Ravazzolo, Aldamaria Puliti
Published in:
BMC Medical Genetics
|
Issue 1/2014
Login to get access
Abstract
Background
Poland Syndrome (PS) is a rare disorder characterized by hypoplasia/aplasia of the pectoralis major muscle, variably associated with thoracic and upper limb anomalies. Familial recurrence has been reported indicating that PS could have a genetic basis, though the genetic mechanisms underlying PS development are still unknown.
Case presentation
Here we describe a couple of monozygotic (MZ) twin girls, both presenting with Poland Syndrome. They carry a de novo heterozygous 126 Kbp deletion at chromosome 11q12.3 involving 5 genes, four of which, namely HRASLS5, RARRES3, HRASLS2, and PLA2G16, encode proteins that regulate cellular growth, differentiation, and apoptosis, mainly through Ras-mediated signaling pathways.
Conclusions
Phenotype concordance between the monozygotic twin probands provides evidence supporting the genetic control of PS. As genes controlling cell growth and differentiation may be related to morphological defects originating during development, we postulate that the observed chromosome deletion could be causative of the phenotype observed in the twin girls and the deleted genes could play a role in PS development.